Scholar Rock’s drug helps preserve lean mass in mid-stage trial
By Thomson ReutersJun 18, 2025 | 6:28 AM
(Reuters) -Scholar Rock said on Wednesday its experimental drug helped overweight patients preserve lean mass in a mid-stage trial when used in combination with Eli Lilly’s weight-loss treatment.
(Reporting by Christy Santhosh in Bengaluru; Editing by Devika Syamnath)
Comments